MR Imaging Biomarkers for the Prediction of Outcome after Radiofrequency Ablation of Hepatocellular Carcinoma: Qualitative and Quantitative Assessments of the Liver Imaging Reporting and Data System and Radiomic Features
Alexandra Petukhova-Greenstein(Yale University), Julius Chapiro(Yale University), Luzie A. Gottwald(Yale University), Tamar H. Taddei(Yale University), Paul DiDomenico(Lucile Packard Children's Hospital), Nathan Chai(Yale University), MingDe Lin(Yale University), Ifeyinwa Onyiuke(VA Connecticut Healthcare System), Bernhard Gebauer(Charité - Universitätsmedizin Berlin), Stefan P. Haider(Yale University), Maria Ciarleglio(Yale University), Ahmet S. Kücükkaya(Yale University), Tal Zeevi(Yale University), Gowthaman Gunabushanam(Yale University), Lawrence H. Staib, John A. Onofrey(Yale University), Margarita V. Revzin(Yale University), Rohil Malpani(Yale University), Junlin Yang(Yale University), Yanhong Deng(Sun Yat-sen University)
Cited by 14
Related Papers
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
|European Journal of Cancer|2011|615
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456